EXACT SCIENCES CORP (EXAS) Cash & Current Investments (2010 - 2025)

Exact Sciences (EXAS) has reported Cash & Current Investments for 16 consecutive years, with $964.7 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Current Investments fell 7.06% year-over-year to $964.7 million; the TTM figure through Dec 2025 stood at $964.7 million (down 7.06% YoY), while the FY2025 annual figure was $964.7 million, down 7.06% from the prior year.
• Cash & Current Investments improved to $964.7 million in Q4 2025 per EXAS's latest filing, from $221.4 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $1.4 billion in Q1 2021 and bottomed at $221.4 million in Q3 2025.
• Historically, Cash & Current Investments has averaged $845.7 million across 5 years, with a median of $797.3 million in 2022.
• Annual changes were most pronounced in 2024 — Cash & Current Investments surged 39.04% — and 2025, when it sank 78.32%.
• Exact Sciences' Cash & Current Investments stood at $1.0 billion in 2021, then plunged by 38.66% to $632.1 million in 2022, then climbed by 23.03% to $777.6 million in 2023, then jumped by 33.48% to $1.0 billion in 2024, then retreated by 7.06% to $964.7 million in 2025.
• Business Quant data shows EXAS's Cash & Current Investments at $964.7 million in Q4 2025, $221.4 million in Q3 2025, and $858.4 million in Q2 2025.